AVNS Q1 2022 Earnings — Avanos Medical, Inc. Revenue & Financial Results | Market Cap Arena

AVNSAvanos Medical, Inc.

$621M

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$197M+9.2% YoY

Gross Profit

$107M54.0% margin

Operating Income

$13M6.6% margin

Net Income

$5M2.7% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

+2.1%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$510M

Stockholders' Equity

$1.3B

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$197M	$181M	+9.2%
Gross Profit	$107M	$93M	+15.2%
Operating Income	$13M	$11M	+18.0%
Net Income	$5M	-$8M	+171.1%

Revenue Segments

Chronic Care

$119M30%

Digestive health

$81M21%

Pain Management

$78M20%

Interventional pain

$39M10%

Acute pain

$39M10%

Respiratory health

$38M10%